Other equities analysts have also recently issued reports about the company. Jefferies Group reiterated a buy rating and issued a $55.00 price objective on shares of INC Research in a report on Friday, November 10th. Robert W. Baird set a $46.00 price objective on INC Research and gave the stock a buy rating in a report on Thursday, November 16th. Zacks Investment Research upgraded INC Research from a hold rating to a buy rating and set a $58.00 price objective for the company in a report on Wednesday, September 27th. SunTrust Banks cut their price objective on INC Research to $50.00 and set a buy rating for the company in a report on Friday, December 1st. Finally, Barclays started coverage on INC Research in a report on Monday, December 11th. They issued an equal weight rating and a $40.00 price objective for the company. One analyst has rated the stock with a sell rating, six have assigned a hold rating and five have assigned a buy rating to the company’s stock. The company has a consensus rating of Hold and a consensus target price of $50.56.
INC Research (INCR) opened at $42.10 on Monday. The firm has a market capitalization of $4,283.36, a PE ratio of 18.83, a price-to-earnings-growth ratio of 1.29 and a beta of 1.08. The company has a quick ratio of 1.27, a current ratio of 1.27 and a debt-to-equity ratio of 0.99. INC Research has a one year low of $33.60 and a one year high of $61.10.
A number of hedge funds have recently modified their holdings of INCR. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in INC Research by 14.8% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,765 shares of the company’s stock valued at $103,000 after acquiring an additional 228 shares during the period. Pacad Investment Ltd. purchased a new stake in INC Research during the 2nd quarter valued at about $123,000. Riverhead Capital Management LLC purchased a new stake in INC Research during the 2nd quarter valued at about $128,000. Victory Capital Management Inc. boosted its holdings in INC Research by 17.6% during the 2nd quarter. Victory Capital Management Inc. now owns 2,377 shares of the company’s stock valued at $139,000 after acquiring an additional 356 shares during the period. Finally, Personal Capital Advisors Corp purchased a new stake in INC Research during the 3rd quarter valued at about $234,000. Institutional investors own 99.50% of the company’s stock.
WARNING: This report was first published by Community Financial News and is the sole property of of Community Financial News. If you are viewing this report on another domain, it was stolen and reposted in violation of US & international trademark and copyright law. The original version of this report can be accessed at https://www.com-unik.info/2017/12/20/inc-research-incr-downgraded-by-thestreet-to-c.html.
About INC Research
INC Research Holdings, Inc is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services.
Receive News & Ratings for INC Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INC Research and related companies with MarketBeat.com's FREE daily email newsletter.